The Cannigma

JANUARY 16, 2023

Psychedelics and mushrooms beyond psilocybin Psilocybin may be the most well-known magic mushroom compound, but it’s far from the only. When people think of magic mushrooms, the most common compound that comes to mind is psilocybin. It’s called amanita muscaria and it is one of the world’s most recognizable mushrooms.

Research and Development 127

Research and Development History Treatment Retail 127

Cannabis Law Report

MAY 2, 2022

Porta Sophia is building an online database and searchable library of historical, scientific and cultural information pertaining to psychedelics that they say will support the work of both innovators and patent examiners to prevent problematic, or “bad,” patents from being granted in the first place. They saw this as a solvable problem.

History 52

History Access Medicine Patients 52

TheAnswerPage

JANUARY 21, 2022

Have any universities and major scientific research institutions formed psychedelic research centers? Also, the Center for the Study of World Religions (CSWR) at the Harvard School of Divinity has announced new programming for psychedelic chaplaincy. Publication: Journal of the Neurological Sciences. Publisher: Elsevier.

History 52

History Programs 52

Cannabis Law Report

JUNE 19, 2022

The Center for Psychedelic Drug Research and Education (CPDRE) was approved by the Ohio State College of Social Work faculty in January, and its director, Assistant Professor of Social Work Alan Davis , officially took the helm in March. Alan Davis. Jason Slot.

Education 52

Education Research and Development Therapy Clinical Trials 52

Cannabis Law Report

SEPTEMBER 14, 2021

Mr Morris will be advising COMPASS on research related to new psychedelic compounds that could be developed into therapies in areas of unmet mental health need. Mr Morris said: “For over a decade, Jason and I have worked together studying the chemistry and pharmacology of psychedelics.

Research and Development 52

Research and Development Therapy Pharmaceutical History 52

Cannabis Law Report

NOVEMBER 1, 2021

In the past few decades, pioneering research has rekindled interest in the therapeutic use of psychedelic substances such as psilocybin, ibogaine, and dimethyltryptamine (DMT). However, most psychedelics were banned in the 70s, when President Nixon launched the U.S. Glenn Cohen. Harvard Law School. Date Written: October 23, 2021.

Research and Development 52

Research and Development Law Clinical Trials Therapy 52

Cannabis Law Report

NOVEMBER 23, 2021

This article was originally published on Psychedelic Spotlight . Psychedelic patents should be limited, according to Harvard Law School experts, who are also warning patent reform is necessary for the psychedelics sector to reach its full potential in addressing the global mental health crisis. Read more at [link].

Law 52

Law Research and Development Therapy Clinical Trials 52

Cannabis Law Report

JUNE 22, 2021

To drive brand awareness of, and access to, HaluGen’s Psychedelics Genetic Test Kit. The test also provides insights into the short- and long-term potential of psychedelic-induced risks, such as psychosis. Vancouver, British Columbia–(Newsfile Corp. – June 22, 2021) – Entheon Biomedical Corp.

Research and Development 66

Research and Development Access History Media 66

Cannabis Law Report

JUNE 1, 2021

Scott Wiener wants to decriminalize psychedelic drugs, and a bill he authored to do just that is still alive halfway through this year’s legislative session. It’s long past time to move beyond our outdated and racist war on drugs-era laws, and embrace humane and science-based drug policy,” Wiener wrote. San Francisco state Sen.

Decriminalization 66

Decriminalization Legislation Conditions History 66

TheAnswerPage

JANUARY 19, 2022

Psilocybin-assisted psychotherapy for depression: Emerging research on a psychedelic compound with a rich history. Psilocybin-assisted psychotherapy for depression: Emerging research on a psychedelic compound with a rich history. Publication: Journal of the Neurological Sciences. Publisher: Elsevier.

History 59

History 59

Cannabis Law Report

MAY 19, 2022

” Hartle, 54, is one of the very few Canadians to have received legal psychedelics psychotherapy for a mental health condition since Health Canada made it easier in January for health-care workers to access psilocybin — the hallucinogenic compound found in some mushrooms. .” Sudbury.com reports. It’s summer.

Therapy 52

Therapy Patients Treatment Clinical Trials 52

Cannabis Law Report

JUNE 16, 2021

Genetic Screening Platform Technology and Data to Strengthen Entheon’s Psychedelic-Assisted Protocols. Lobo also has various existing distribution and partner relationships both domestically and internationally that are a strategic fit with Entheon’s goal of expanding its personalized psychedelics platform globally.

Research and Development 105

Research and Development Data Conditions Events 105

Cannabis Law Report

FEBRUARY 28, 2022

In the past two decades, pioneering research has rekindled interest in the therapeutic use of psychedelic substances such as psilocybin, ibogaine, and dimethyltryptamine (DMT). However, most psychedelics were banned in the ‘70s, when President Nixon launched the U.S. war on drugs. Because they were criminalized for decades, the U.S.

Research and Development 52

Research and Development Therapy Law Clinical Trials 52

TheAnswerPage

JANUARY 20, 2022

Psilocybin-assisted psychotherapy for depression: Emerging research on a psychedelic compound with a rich history. Psilocybin-assisted psychotherapy for depression: Emerging research on a psychedelic compound with a rich history. Publication: Journal of the Neurological Sciences. Publisher: Elsevier.

Blood Pressure 59

Blood Pressure History 59

Cannabis Law Report

NOVEMBER 24, 2019

There’s a lot of interest in the subject, we reported last week on a psychedelics investment conference being held in New York (hosted By Green Market News). The growth and management of psychedelics regulation will be equally chaotic, but we think just as fast as the cannabis sector. Psychedelics in the News.

Therapy 59

Therapy Treatment Medicine Clinical Trials 59

TheAnswerPage

JANUARY 18, 2022

Psilocybin-assisted psychotherapy for depression: Emerging research on a psychedelic compound with a rich history. Publication: Journal of the Neurological Sciences. Yes, it is converted to the active metabolite psilocin. The chemical structure of psilocin is similar to the structure of serotonin. Publisher: Elsevier.

History 59

History 59

Cannabis Law Report

JUNE 24, 2021

( CSE: SILO) (OTC: SILFF) has launched Marley One , a psychedelic mushroom consumer brand, in collaboration with the family of legendary musician Bob Marley. These initial mushroom supplements have no psychoactive properties, but Silo said it is planning a psychedelic mushroom product line under the Marley name later this year.

Sleep 66

Sleep Digestion Tincture History 66

SpeedWeed

AUGUST 6, 2021

Neil deGrasse Tyson joined a comedian and ecologist as co-hosts on science podcast StarTalk Radio last week to discuss the “wonderful world of fungi”—with a selective emphasis on psilocybin mushrooms. You’ll learn about the origins of the classification of the kingdom fungi and the use of psychedelic mushrooms. Tyson wondered.

History 52

History Vaping Topical Legalization 52

Cannabis Law Report

SEPTEMBER 12, 2022

( CSE: OPTI ) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), is pleased to announce that it has completed what it believes to be the largest legal natural psilocybin harvest in Canadian history. Optimi Chief Operations Officer, Bryan Safarik, says the yield exceeded expectations in terms of quality and quantity. “By

History 52

History Clinical Trials Legalization Research and Development 52

Cannabis Law Report

JULY 28, 2021

The Company and Its Subsidiary KGK Science Have Also Completed the Pre-Qualification Audits of Its Canadian Facilities to Enable Clinical Trials in an Arrangement with Aleafia Health. The audits will enable KGK to conduct clinical trials in the areas of psychedelics and nutraceuticals, among other substances of study.

Clinical Trials 81

Clinical Trials Research and Development Treatment Therapy 81

Cannabis Law Report

SEPTEMBER 20, 2021

Delic Holdings Corp (“ Delic ” or the “ Company “) (CSE: DELC ) (OTCQB: DELCF ) (FRA: 6X0 ), the leading psychedelic wellness platform today announced it has entered into a binding merger agreement (the “ Merger Agreement “) with Ketamine Wellness Centers Arizona LLC (“ KWC “). Transaction Highlights. experience and knowledge to Delic.

Treatment 52

Treatment Media Research and Development Patients 52

The Cannigma

JULY 3, 2023

Happily, the body of research into cannabis and psychedelics (including MDMA) is expanding fast, and it’s likely that better data on their interactions will become available in the near future. Roughly speaking, MDMA (3,4-methylenedioxymethamphetamine) is a psychedelic and a stimulant (an amphetamine derivative). That’s around 2.5

Research and Development 46

Research and Development Environment THC Microdosing 46

Cannabis Law Report

MARCH 2, 2020

The global march toward cannabis legalization has seemingly awoken another long dormant area of scientific interest: psychedelics as medicine. In lockstep with the FDA’s more open-minded approach toward psychedelic medicine, Denver, Oakland, and Santa Cruz all decided to decriminalize magic mushrooms. In 2018, the U.S.

Medicine 59

Medicine Therapy DEA Pharmaceutical 59

Cannabis Law Report

NOVEMBER 17, 2021

The constitutional convention saw the campaign to reschedule psilocybin elevated to national headlines, and a week later British psychedelic company COMPASS Pathways released data from its pivotal Phase IIb trial with psilocybin, which demonstrated its efficacy in treatment-resistant depression.

Policy 52

Policy Data Treatment History 52

Cannabis Law Report

JULY 7, 2021

Mr. Deffett will continue to perform his duties as VP Capital Markets while holding the title of Interim CEO. Deffett will continue to perform his duties as VP Capital Markets while holding the title of Interim CEO. to a company dedicated to mental healthcare and the rebrand to Ketamine One,” said Adam Deffett, Interim CEO of Ketamine One. “I

Research and Development 98

Research and Development Treatment Therapy Banking 98

Cannabis Law Report

SEPTEMBER 17, 2019

Explore the myth, magic, and science of psilocybin in our four day online summit. We’ll explore history , learning about traditional and indigenous use. Our experts invite you into a mind expanding adventure into the realms of psychedelic awareness. Here at CLR we believe it’s an important area to watch. Cultivation.

Policy 45

Policy Decriminalization History Access 45

Cannabis Law Report

NOVEMBER 9, 2021

Established history of providing FDA-approved ketamine infusion services: The management team at KWC has been in business for 6 years expanding services throughout the United States. In this new role, Nicholson will focus on the growth and expansion of the psychedelic wellness clinics for the company. multiple voting shares.

Treatment 52

Treatment Therapy Media Access 52

SpeedWeed

AUGUST 11, 2021

MAPS, The Multidisciplinary Association for Psychedelic Substances, was awarded a $12,979,050 million grant from the state of Michigan to fund a study on PTSD and cannabis on August 10. MAPS Makes History. Four trial sites will be set up, two of which will be located in Michigan.

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical DEA 52

SpeedWeed

MAY 22, 2021

Your aunt (the cool one) now sends you sporadic articles of how the same psychedelics you used to talk about self-transforming machine elves with are now the subject of numerous studies to treat an array of cognitive disorders like depression, PTSD, alcoholism, and severe drug addiction, to name a few. The Science of Neuroimaging.

Research and Development 52

Research and Development Microdosing Wellness and Beauty Pets 52

SpeedWeed

MARCH 18, 2021

million grant from the Colorado Department of Public Health and Environment (CDPHE) to the Multidisciplinary Association of Psychedelic Studies (MAPS). million grant from the Colorado Department of Public Health and Environment (CDPHE) to the Multidisciplinary Association of Psychedelic Studies (MAPS). 76 veterans in the study.

Clinical Trials 40

Clinical Trials THC Strains Cannabis 40

Cannabis Law Report

DECEMBER 15, 2021

Here’s what he published this week… Putting my money where my mouth is with atai Life Sciences. I believe that atai Life Sciences (NASDAQ: ATAI), the mental health company I have founded in 2018, is the biggest entrepreneurial opportunity I have ever encountered. Extension of my lock-up for another 24 months.

Research and Development 52

Research and Development Data History Patients 52

Cannabis Law Report

DECEMBER 7, 2021

Ibogaine is a powerful psychedelic substance. Derived from the iboga shrub native to West Africa, it has a history as a spiritual sacrament in the Bwiti religion in the country of Gabon. His ibogaine analog, which he has dubbed Delix-7, is not psychedelic. By cutting it down, we got rid of these undesired side effects.”.

Treatment 52

Treatment Clinical Trials Data Conditions 52

Cannabis Law Report

DECEMBER 19, 2021

Psychedelic Justice is a reminder that, as the contributor Alexander Belser puts it, “we have rainbow skeletons in our closet.” For forty years, the Addiction Research Center coerced federal prisoners—predominantly African American men and other marginalized populations—into dangerously high-dose psychedelic experimentation. .

Therapy 52

Therapy History Medicine Extraction 52

Cannabis Law Report

APRIL 8, 2022

On April 8, 1986—36 years ago today—the Multidisciplinary Association for Psychedelic Studies (MAPS) was founded by Rick Doblin, Ph.D., as a non-profit organization to fulfill the need to broaden psychedelic research, therapy, and develop legal options for psychedelic medicine. Rick Doblin, Ph.D., MAPS Founder Rick Doblin, Ph.D.,

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

SpeedWeed

JULY 7, 2021

One single dose of mescaline may be a helpful treatment for people who are struggling with addiction, depression, anxiety, or PTSD , according to a new study published in the ACS Pharmacology & Translational Science journal. . Mescaline-containing San Pedro cactus (Image via ).

Clinical Trials 52

Clinical Trials Treatment Decriminalization Conditions 52

Cannabis Law Report

NOVEMBER 2, 2021

We got 51 hemp-derived Delta-8 THC products tested by an independent lab, and found high levels of Delta-9 THC in most of them. And that was just the beginning. This is a well researched and detailed report and is, we suggest required reading. But it can’t really be as bad as it sounds, can it? Unfortunately, the news is not good. Table of Contents.

THC 96

THC CBD Legalization Vaping 96

The Cannigma

APRIL 8, 2021

In this episode with Dr. Peterson, we discuss common mistakes people make when they use cannabis, and why new cannabis technologies and products can get a little too far ahead of the science sometimes. The law states, you must be ensured the opportunity to speak with someone like me.” . Music by Desca. CP: I mean, pick away.

Medicine 108

Medicine Cannabinoids Cannabis THC 108